Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Predictive Power
100%
Segmentation-based
100%
Deep Learning
100%
Overall Survival
64%
Disease-specific Survival
64%
Local Recurrence-free Survival
57%
Standard of Care
21%
Non-small Cell Lung Cancer Patients
14%
Stereotactic Body Radiotherapy
14%
Computer-based
14%
Predictive Methods
14%
Auto-segmentation
14%
Radiotherapy
7%
Survival Outcomes
7%
External Data
7%
Treatment History
7%
Low Risk
7%
High-risk Population
7%
Computational Imaging
7%
Serial Assessment
7%
Stereotactic Body
7%
Risk Category
7%
Prediction Method
7%
Stanford University
7%
Stage History
7%
Unsupervised Features
7%
Survival Risk
7%
Deep Segmentation Networks
7%
Medicine and Dentistry
Prognostication
100%
Non Small Cell Lung Cancer
100%
Overall Survival
75%
Disease Specific Survival
75%
Progression Free Survival
66%
Stereotactic Body Radiation Therapy
25%
Clinical Stage
8%
Computer Assisted Tomography
8%
High Risk Population
8%
Low Risk Population
8%
Treatment History
8%
Immunology and Microbiology
Overall Survival
100%
Disease Specific Survival
100%
Lung
100%
Progression Free Survival
88%
High Risk Population
11%
Low Risk Population
11%
Computer Assisted Tomography
11%